EP1137956A1 - Cristallins artificiels fabriques a partir de compositions polymeres - Google Patents

Cristallins artificiels fabriques a partir de compositions polymeres

Info

Publication number
EP1137956A1
EP1137956A1 EP99965729A EP99965729A EP1137956A1 EP 1137956 A1 EP1137956 A1 EP 1137956A1 EP 99965729 A EP99965729 A EP 99965729A EP 99965729 A EP99965729 A EP 99965729A EP 1137956 A1 EP1137956 A1 EP 1137956A1
Authority
EP
European Patent Office
Prior art keywords
cross
linked polymeric
polymeric material
monomeric component
chain alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99965729A
Other languages
German (de)
English (en)
Inventor
Harish C. Makker
Xiugao Liao
Joseph I. Weinschenk, Iii
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johnson and Johnson Surgical Vision Inc
Original Assignee
Allergan Sales LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/265,720 external-priority patent/US6241766B1/en
Priority claimed from US09/286,356 external-priority patent/US6245106B1/en
Application filed by Allergan Sales LLC filed Critical Allergan Sales LLC
Publication of EP1137956A1 publication Critical patent/EP1137956A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G02—OPTICS
    • G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B1/00—Optical elements characterised by the material of which they are made; Optical coatings for optical elements
    • G02B1/04—Optical elements characterised by the material of which they are made; Optical coatings for optical elements made of organic materials, e.g. plastics
    • G02B1/041—Lenses
    • G02B1/043—Contact lenses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/16—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/16—Materials or treatment for tissue regeneration for reconstruction of eye parts, e.g. intraocular lens, cornea

Definitions

  • the present invention relates to ophthalmic lenses made from polymeric compositions. More particularly, the invention relates to ophthalmic lenses, preferably deformable intraocular lenses, having reduced surface tackiness made from acrylate and/or methacrylate-based polymeric compositions.
  • Intraocular lenses have been known for a long time, since shortly after the end of World War II.
  • Such a lens is surgically implanted into a mammalian eye, e.g., human eye, to replace a damaged or diseased natural lens of the eye and restore the patient's vision.
  • IOLs are made from “hard” or “rigid” polymeric or glass optical materials, such as polymethyl methacrylate (which has a refractive index of 1.49), soft resilient polymeric materials, such as silicones, have been increasingly used, for the reasons discussed below, in ophthalmic applications.
  • the deformable IOL must have sufficient structural integrity, elasticity and elongation and be small enough in size to permit deforming for insertion through a small incision. After insertion, the lens must, of course, regain its original shape and have sufficient structural integrity to retain such shape under normal use conditions .
  • the thinner the deformable IOL the smaller the incision in the eye that is required.
  • the lens in order to function optically as an IOL, the lens must have sufficient optical refractory power.
  • the higher the optical refractive index of the material making up the IOL the thinner the IOL can be and still obtain the same optical refractory power.
  • Deformable IOLs made of acrylic materials can be quite tacky in nature, which tackiness inhibits deforming to a sufficiently small size for insertion through a very small incision and/or may cause handling problems
  • U.S. Patent 4,834,750 discloses IOLs with optics made of copolymers of methacrylate esters which form homopolymers that are relatively hard at room temperature and acrylate esters which form homopolymers that are relatively soft at room temperature. Such copolymers are cross-linked with a diacrylate ester to produce an acrylate material which preferably includes a constituent derived from a fluoroacrylate to reduce surface tackiness . None of the specific monomers disclosed in this patent provide homopolymers which have a refractive index of at least about 1.50. Weinschenk, III U.S. Patent 5,331,073 discloses acrylic-based intraocular lenses which optionally include a constituent derived from a hydrophilic monomeric component. This constituent is effective to reduce the tackiness of the copolymer. However, such hydrophilic constituent may cause a disadvantageous decrease in the index of refraction of the final IOL optic in that some water is included within the copolymer.
  • LeBoeuf et al U.S. Patent 5,603,774 discloses plasma treatment of the polymer surface to reduce tackiness associated with certain acrylic polymers, particularly those polymers useful in intraocular lenses.
  • plasma treatment does involve an additional manufacturing step.
  • the non-homogeneous intraocular lens which results from the surface being treated with plasma has the potential of causing problems in the eye.
  • ophthalmic lens materials of construction which have good optical properties, including optical clarity and high refractive index (index of refraction) and, in addition, have reduced tackiness without the disadvantages of the prior art materials noted above.
  • New polymeric materials and ophthalmic lenses, for example, IOLs, produced from such polymeric materials have been discovered.
  • the present polymeric materials are derived from a combination of monomers and provide very useful optical properties in terms of optical clarity and high index of refraction and can be formed into ophthalmic lenses, for example, optics of IOLs which are effectively deformable, preferably foldable, for insertion through small surgical incisions, preferably on the order of about 3 mm or less (in maximum transverse dimension) .
  • the present compositions and ophthalmic lenses have reduced surface tackiness without requiring the presence of fluoroacrylates, hydrophilic components and without requiring plasma treatment .
  • the monomeric components used to produce the present compositions and ophthalmic lenses in accordance with the present invention By selecting the monomeric components used to produce the present compositions and ophthalmic lenses in accordance with the present invention, reduced surface tackiness is achieved with little or no adverse impact on the optical clarity, refractive index, homogeneity, biocompatability, deformability, and cost of production of such compositions and ophthalmic lenses.
  • the present compositions and lenses can be produced using conventional techniques, e.g., conventional polymerization techniques.
  • the present invention is very effective and easy to practice and results in polymeric compositions and ophthalmic lenses which have outstanding properties.
  • ophthalmic lens bodies which comprise cross- linked polymeric materials or compositions.
  • Such materials comprise a first constituent derived from a first monomeric component selected from acrylates, methacrylates and mixtures thereof.
  • a second constituent is included and is derived from a second component in an amount effective as a cross linker in the cross-linked polymeric material.
  • the cross-linked polymeric material has branched chain alkyl groups in an amount effective to reduce the tackiness of the cross-linked polymeric material relative to a substantially identical cross-linked polymeric material without the branched chain alkyl groups.
  • the present ophthalmic lens bodies may be in the form of optics of IOLs, contact lenses, corneal implants (for example, corneal onlays and corneal inlays) and other ophthalmic lens bodies.
  • the present lens bodies are particularly useful as optics of IOLs, more preferably deformable IOLs . Because a deformable IOL is adapted to be deformed, that is rolled, folded or otherwise deformed, prior to insertion into the eye, it is important that the IOL optic have a relatively reduced degree of surface tackiness to provide for effective deforming for insertion and/or to allow the optic to effectively regain its original shape in the eye .
  • branched chain alkyl groups refers to alkyl groups which are non-linear. Thus, at least one, and preferably more than one, carbon atom in the alkyl group is located in one or more branches, rather than being located in a single linear portion of the alkyl group. Also, cycloalkyl groups are, by definition, branched chain alkyl groups.
  • the branched chain alkyl group may be of any size suitable to function as described herein.
  • the branched chain alkyl group has about 3 to about 20 carbon atoms and more preferably about 6 to about 15 carbon atoms.
  • the amount of branched chain alkyl groups present is sufficient to provide a cross-linked polymeric material having reduced tackiness relative to a substantially identical cross-linked polymeric material without the branched chain alkyl groups.
  • the monomeric component for example, the first monomeric component, or portion thereof, including the branched chain alkyl groups used in providing the present cross-linked polymeric materials may represent a wide ranging proportion of the total monomeric components employed.
  • the branched chain alkyl group- containing monomeric component, or portion thereof provides a constituent of the cross-linked polymeric materials which is present in an amount in the range of about 1% or less to about 50% or more, and more preferably about 3% to about 25%, by weight of the cross-linked polymeric material.
  • the first monomeric component preferably is selected from acrylates including a branched chain alkyl group, methacrylates including a branched chain alkyl group and mixtures thereof .
  • the cross-linked polymeric material includes a third constituent derived from a third monomeric component other than the first and second monomeric components .
  • This third monomeric component is selected from acrylates, methacrylates and mixtures thereof.
  • the first monomeric component is selected from acrylates having a branched chain alkyl group and mixtures thereof .
  • the third monomeric component preferably is selected from methacrylates and mixtures thereof .
  • the present cross-linked polymeric material has reduced tackiness relative to a substantially identical cross-linked polymeric material in which the first constituent is replaced by a constituent derived from a monomeric component having a straight chain alkyl group having the same number of carbon atoms as the branched chain alkyl groups of the first monomeric component.
  • the cross-linked polymeric material has an index of refraction of at least about 1.50.
  • Relatively high indexes of refraction allow the ophthalmic lenses, and in particular IOLs, to be conveniently manufactured with relatively high optical powers and the capability of being passed through scleral tunnel incisions of about 3.0 mm or even about 2.8 mm or less.
  • the cross-linked polymeric material includes aryl- containing groups in an amount effective to increase the index of refraction of the cross-linked polymeric material relative to the index of refraction of a substantially identical cross-linked polymeric material without the aryl- containing groups .
  • the third monomeric component includes an effective amount of aryl- containing groups to increase the index of refraction of the cross-linked polymeric material, as desired.
  • the cross-linked polymeric material preferably has a glass transition temperature (Tg) of about 22°C or less.
  • Tg glass transition temperature
  • Fig. 1 is a plan view of an IOL in accordance with the present invention.
  • Fig. 2 is a side view of the IOL of Fig. 1.
  • the present ophthalmic lens bodies comprise cross- linked polymeric materials as described herein.
  • Such cross-linked polymeric materials comprise a combination of constituents derived from different monomeric components.
  • the present cross-linked polymeric materials comprise a first constituent and a second constituent, and preferably a third constituent.
  • the first constituent of the present cross-linked polymeric materials is derived from a first monomeric component selected from the group consisting of acrylates, methacrylates and mixtures thereof . At least a portion of the first monomeric component preferably is selected from acrylates including a branched chain alkyl group, methacrylates including a branched chain alkyl group and mixtures thereof.
  • the present cross-linked polymeric materials have branched chain alkyl groups in an amount effective to reduce the tackiness of the cross-linked polymeric materials relative to a substantially identical cross- linked polymeric materials without the branched chain alkyl groups.
  • the first monomeric component, or portion thereof includes branched chain alkyl groups, such first monomeric component, or portion thereof, is preferably present in an amount to provide an effective tackiness reducing amount of the branched chain alkyl groups .
  • the branched chain alkyl group-containing monomeric component for example, the first monomeric component, or portion thereof, preferably provides a constituent of the cross-linked polymeric material which is present in an amount in the range of about 1% or less to about 50% or more, more preferably about 3% to about 25% by weight, of the total cross-linked polymeric material.
  • Homopolymers of the first monomeric component preferably have a Tg of less than about 30°C, more preferably less than about 22°C.
  • Typical examples of the first monomeric component include, but are not limited to 2-ethylhexyl acrylate, 2- ethylhexyl methacrylate, 2 , 2-dimethylpropyl acrylate, 2,2- dimethylpropyl methacrylate, trimethylcyclohexyl acrylate, trimethylcyclohexyl methacrylate, isobutyl acrylate, isobutyl methacrylate, isopentyl acrylate, isopentyl methacrylate and mixtures thereof .
  • the second constituent of the present cross-linked polymeric materials is derived from a second monomeric component in an amount effective as a crosslinker in the present cross-linked polymeric materials.
  • This second monomeric component preferably is multi-functional and can chemically react with the first monomeric component, and more preferably with both the first and third monomeric components.
  • the second constituent of the present cross- linked polymeric materials is present in an amount effective to provide a desired degree of shape memory to the materials, for example, to facilitate returning a deformed IOL made from the present cross-linked polymeric material to its original shape, for example, in a reasonable period of time, at the conditions present in the human eye .
  • the second or cross linking monomeric component is often present in a minor amount relative to the amounts of the first and third monomeric components.
  • the second constituent is present in the cross-linked polymeric material in an amount of less than about 1% by weight of the material.
  • the second constituent of the present cross- linked polymeric materials may be considered to be a cross linker.
  • the cross linking monomeric component is often selected from multi functional components, preferably able to chemically react with at least one functional group of each of the first monomeric component and the third monomeric component.
  • the cross linking monomeric component is chosen to be chemically reactable with at least one functional group associated with one or both of the first monomeric component and the third monomeric component .
  • Examples of the second monomeric component for use in the present cross-linked polymeric materials include, but are not limited to, ethylene glycol dimethacrylate, tetraethylene glycol dimethacrylate, allyl acrylate, allyl methacrylate, trifunctional acrylates, trifunctional methacrylates, tetrafunctional acrylates, tetrafunctional methacrylates and mixtures thereof.
  • the third monomeric component used in producing the cross-linked polymeric materials of the present invention is different from the first and second monomeric components. Such third monomeric component is selected from acrylates, methacrylates and mixtures thereof.
  • the third constituent of the present cross-linked polymeric materials preferably is present to provide a constituent of the cross-linked polymeric material in an amount of at least about 10% or about 20% by weight, and more preferably in a major amount (at least about 50%) by weight, of the cross-linked polymeric material.
  • the third constituent is derived from a third monomeric component the homopolymers of which have an index of refraction of at least about 1.50, preferably at least about 1.52 or about 1.54.
  • the homopolymers of the third monomeric component may have a substantial degree of rigidity.
  • the first and third constituents together are preferably at least about 80%, more preferably at least about 90%, by weight of the present cross-linked polymeric materials.
  • the first and third monomeric components preferably are selected so that each of these monomeric components can chemically react with the other monomeric component .
  • the present cross-linked polymeric materials have reduced surface tackiness and preferably are optically clear and have high indexes of refraction, for example, at least about 1.50, and preferably at least about 1.52 or at least about 1.54.
  • the combination of properties of the present cross-linked polymeric materials, for example, which facilitates the manufacture of effectively deformable IOLs having high optical power, is very advantageous.
  • the term "homopolymer” refers to a polymer which is derived substantially completely from the monomeric component in question.
  • such homopolymer includes as the primary, preferably sole, monomeric component, the monomeric component in question. Minor amounts of catalysts, initiators and the like may be included, as is conventionally the case, in order to facilitate the formation of the homopolymer.
  • the homopolymers of both the first monomeric component and the third monomeric component have sufficiently high molecular weights or degrees of polymerization so as to be useful as IOL materials of construction.
  • the homopolymers of the third monomeric component may be rigid.
  • An IOL made from such a "rigid" homopolymer is not deformable, for example, using systems which are specifically structured and used to deform IOLs for insertion through a small incision into the eye.
  • the rigidity of the homopolymer of the third monomeric constituent may result in an IOL made from such homopolymer being not deformable, or breaking or otherwise deteriorating as a result of the application of force seeking to so deform such IOL for implantation through a small ocular incision.
  • the third constituent preferably is present in an amount of at least about 10% or at least about 20%, more preferably in a major amount, by weight of the present cross-linked polymeric materials.
  • the third monomeric component from which the third constituent is derived may be selected from compounds which meet the criteria set forth herein for such component.
  • This monomeric component preferably is such as to provide the present cross-linked polymeric materials with increased refractive index relative to the homopolymers of the first monomeric component .
  • the homopolymers of the third monomeric component preferably have an index of refraction of at least about 1.50, and more preferably at least about 1.52 or at least about 1.54.
  • the third monomeric component is characterized as including one or more aryl -containing groups.
  • the presence of such aryl-containing groups in the third monomeric component at least facilitates, and preferably leads to or results in, the present cross-linked polymeric materials having desirably high refractive indexes.
  • the third monomeric component includes one or more aryl- containing groups, it is preferred that at least the first monomeric component, and more preferably that the first and second monomeric components, include no aryl-containing groups.
  • This "single index of refraction control" is very effective in achieving high index of refraction cross- linked polymeric materials, and allows flexibility in selecting the other monomeric component or components so that cross-linked polymeric materials with advantageous properties, other than index of refraction, for example, cross-linked polymeric materials formable into IOLs which can be effectively deformed (for insertion) at room temperature, can be obtained.
  • Examples of the third monomeric component which may be included in the present cross-linked polymeric materials include, but are not limited to, benzyl acrylate, benzyl methacrylate, phenyl acrylate, phenyl methacrylate, phenoxyalkyl acrylates, phenoxyalkyl methacrylates, phenylalkyl acrylates, phenylalkyl methacrylates, carbazole acrylates, carbazole methacrylates, biphenyl acrylates, biphenyl methacrylates, naphthyl acrylates, naphthyl methacrylates and mixtures thereof.
  • first, second and third monomeric components should be such as to provide cross-linked polymeric materials which are compatible for use in or on the eye, are optically clear and are otherwise suitable for use as materials of construction for ophthalmic lenses.
  • each of the first, second and third monomeric components is substantially free of silicon, so that the resulting copolymer is not a silicone polymer.
  • the monomeric components may be substituted with substantially non-interfering substituents which have a substantial detrimental effect on the cross-linked polymeric materials produced therefrom.
  • substituents may include one or more elements, such as oxygen, nitrogen, carbon, hydrogen, halogen, sulfur, phosphorus, and the like and mixtures and combinations thereof.
  • the cross-linked polymeric materials of the present invention preferably have glass transition temperatures (Tg) of about 22°C or less. Such glass transition temperatures (Tg) are beneficial in facilitating the deforming (folding) of an IOL the optic of which is made of an embodiment of the present cross-linked polymeric material at room temperature prior to inserting the IOL through a small incision into the eye.
  • the present cross-linked polymeric materials may be produced using conventional polymerization techniques.
  • the monomers can be blended together, cast into the form of a sheet, and heated to an elevated temperature, such as in a range of about 50°C to about 90°C for a period of time in a range of about 30 minutes to about 8 hours or about 24 hours or more, to facilitate the polymerization reaction.
  • Catalysts and/or initiators for example, selected from materials well known for such use in the polymerization art, may be included in the monomer mix in order to promote, and/or increase the rate of, the polymerization reaction.
  • initiators examples include 2,2'-azobis (2, 4-dimethylpentanenitrile) , 2,2'- azobis (2-methylpropanenit ile) , 2,2'-azobis (2- methylbutanenitrile) , peroxides such as benzoyl peroxide, UV initiators such as dietho yacetophenone, and the like and mixtures thereof.
  • effective amounts of ultraviolet light absorbing monomeric components such as functional benzotriazole and benzophenone derivatives, may be included in the precursor monomer mix. Such UV light absorbing monomeric components are polymerized into the final cross- linked polymeric material to provide the final material with effective UV light absorbing properties.
  • the present cross-linked polymeric materials are produced by mixing together the first monomeric component and the third monomeric component. This mixture is well blended, deareated and heated to a temperature, for example, of about 50°C to about 80°C and maintained at this temperature for a period of time, for example, of about 15 minutes to about 3 hours. The mixture undergoes partial polymerization to form a viscous liquid when cooled to about 25°C.
  • the final cross-linked polymeric materials can be produced by combining this partially polymerized viscous liquid, the second or cross linking monomeric component and catalyst and/or an initiator. Alternately, all the monomeric components and catalyst and/or initiator can be combined or mixed together.
  • the viscous liquid, or monomeric mixture is well blended, deareated and poured into a mold.
  • the mold is heated, preferably to a temperature of about 40°C to about 100°C, and the liquid or mixture is allowed to cure, preferably for about 1 hour to about 24 hours.
  • the material in the mold is then post- cured, preferably at a temperature in the range of about 70°C to about 130°C, for a period of time, preferably for about 2 to about 30 hours. After curing (and post-curing) , the mold is disassembled and the molded lens body recovered.
  • IOL 21 is illustrated as including a pair of radially outwardly extending haptics or fixation members 28 secured to optically clear optic 26.
  • the optic and fixation members can be formed from a single piece of material.
  • Each haptic 28 has a substantially uniform cross section throughout its length and is shown provided with a smoothly curved region 32, intermediate a lens bonding region 34 and a free end region 36.
  • Optic 26 is made of a cross-linked polymeric material in accordance with the present invention, for example, the material as set forth in Example 1 hereof.
  • Optic 26 can be formed in accordance with conventional IOL optic forming techniques, such as by injection molding, sheet casting and cutting to form bottons and the like techniques .
  • the monomeric components can be first mixed in a tube and then cured in the tube. The resulting rod then is cut into buttons which are then cryolathed into IOL optics .
  • each haptic 28 comprises a flexible member comprising metal or, preferably, polymeric material, and having a substantially circular cross-section, although alternative cross-sectional configurations may be substituted, if desired.
  • the haptics may take on any suitable configuration, the illustrated haptics 28 are relatively thin and flexible, while at the same time being sufficiently strong to provide support for IOL 21 in eye 10.
  • the haptics 28 may comprise any of a variety of materials which exhibit sufficient supporting strength and resilience, and which are substantially biologically inert in the intended in vivo environment .
  • Suitable materials for this purpose include, for example, polymeric materials such as polyamides, polyimides, polyacrylates, 2-hydroxy- methylmethacrylate, poly (vinylidene fluoride) , polytetrafluoroethylene and the like; and metals such as stainless steel, platinum, titanium, tantalum, shape-memory alloys, e.g., nitonal, and the like.
  • the haptics can be produced using conventional and well known forming techniques.
  • the preferred polymeric haptics can be formed in accordance with known thermoplastic polymer forming techniques, such as by injection molding or by extrusion.
  • the lens bonding regions 34 of the haptics 28, which, as described herein, are secured to optic may be provided with any of a variety of configurations, such as an anchoring loop, an anchoring "T" , or other anchor structure, to provide a mechanical interlock with the optic, such as has been done in the prior art.
  • IOL 26 can be formed using any one of various techniques, such as those conventionally used to form IOLs.
  • the lens bonding regions 34 of haptics 28 can be placed in a mold which is filled with a mix of the monomeric components used to form the optic 26. The mold is then subjected to conditions, e.g., elevated temperature, effective to form the cross-linked polymeric materials of the present invention from this monomer mix.
  • the lens bonding regions 34 become bonded to the optic 26, thereby securing the haptics 28 to the optic.
  • the haptics 28 can be secured in recesses provided in the already formed optic 26.
  • Optic 26 has low or reduced surface tackiness, and preferably an index of refraction of at least about 1.50.
  • Optic 26 is foldable for insertion into a human eye through an incision of about 3mm in length. After insertion into the eye in the folded condition, IOL 21 returns to its original shape in a reasonable period of time, for example, on the order of about 1 second or about 20 seconds to about three minutes, and can be easily positioned in the eye for effective and long term use as a replacement for the natural lens normally present in the eye.
  • the following formulation is blended, purged with nitrogen for 3 minutes and then cured into a cross-linked copolymer.
  • the resulting cross-linked copolymer has an index of refraction of 1.54, a glass transition temperature (Tg) of 15°C, excellent optical transparency (clarity) and good mechanical properties, including low or reduced tackiness.
  • Tg glass transition temperature
  • a one cm diameter rod of this copolymer is folded 180° with no cracking and returns to its original shape within a few seconds at 35°C.
  • an optic is formed from the crosslinked copolymer produced in Example 1.
  • the optic center thickness is approximately 0.737 mm.
  • EXAMPLE 3 An IOL is produced having an optic as indicated in Example 2. Two substantially opposing haptics, such as shown in Figs. 1 and 2, made from extruded poly methyl methacrylate filaments are bonded to this optic. The resulting IOL is inserted into the eye through a 3 mm surgical incision. In order to accomplish such insertion, the IOL is folded. Upon being released into the eye, the IOL regains its original shape in less than one minute and is fixed in position in the eye. After normal healing, the IOL is effective and useful in the eye as a replacement for the natural lens normally present in the eye.
  • Example 4 The cross-linked polymer of Example 1 (Example 1 Copolymer) and a cross-linked copolymer similar to the cross-linked copolymer produced in Example 1 (Example 4 Copolymer) are made or cast in the form of sheets. Both copolymers are made in a manner similar to how the copolymer of Example 1 is made.
  • the composition of the Example 4 Copolymer is similar to the copolymer of Example 1 except that n-nonyl acrylate is used in place of 3,5,5- trimethylhexyl acrylate .
  • a series of discs shaped and sized similar to optics of intraocular lenses are produced from each of these sheets.
  • a lens folding forceps is used to fold these discs in half (180°) .
  • the disc is released from the forceps into a beaker containing water at 35°C.
  • the amount of time required for the disc to release from itself referred to as the "tack time”
  • the amount of time required of the disc to return to flatness or its original shape referred to as the "unfold time” is recorded.
  • Example 1 Copolymer has reduced tackiness relative to the Example 4 Copolymer. Since substantially the only difference in these two materials is the presence of a monomer including a branched chain alkyl group, that is 3 , 5, 5-trimethylhexyl acrylate, in the Example 1 Copolymer, these results make clear that this type of monomer is surprisingly effective in advantageously reducing the tackiness of cross-linked copolymers derived from such monomers, and in particular ophthalmic lenses including such copolymers .

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Eyeglasses (AREA)

Abstract

L'invention porte sur des lentilles ophtalmiques telles que des cristallins artificiels qui comprennent des matériaux polymères réticulés possédant un premier constituant dérivé d'un premier composant monomère sélectionné dans le groupe comprenant des acrylates, des méthacrylates et des mélanges de ceux-ci, et un second constituant dérivé d'un second composant dans une quantité efficace agissant comme agent de réticulation dans un matériau polymère réticulé. Le matériau polymère réticulé comporte des groupes alkyle à chaîne ramifiée, de préférence avec au moins une partie du premier composant monomère, dans une quantité efficace de façon à réduire le pouvoir adhésif du matériau polymère réticulé par rapport à un matériau polymère réticulé pratiquement identique sans les groupes alkyle à chaîne ramifiée.
EP99965729A 1998-10-29 1999-10-25 Cristallins artificiels fabriques a partir de compositions polymeres Withdrawn EP1137956A1 (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US10638198P 1998-10-29 1998-10-29
US106381P 1998-10-29
US09/265,720 US6241766B1 (en) 1998-10-29 1999-03-09 Intraocular lenses made from polymeric compositions
US265720 1999-03-09
US09/286,356 US6245106B1 (en) 1998-10-29 1999-04-05 Intraocular lenses made from polymeric compositions and monomers useful in said compositions
US286356 1999-04-05
PCT/US1999/024982 WO2000026698A1 (fr) 1998-10-29 1999-10-25 Cristallins artificiels fabriques a partir de compositions polymeres

Publications (1)

Publication Number Publication Date
EP1137956A1 true EP1137956A1 (fr) 2001-10-04

Family

ID=27380106

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99965729A Withdrawn EP1137956A1 (fr) 1998-10-29 1999-10-25 Cristallins artificiels fabriques a partir de compositions polymeres

Country Status (6)

Country Link
EP (1) EP1137956A1 (fr)
JP (2) JP2002529759A (fr)
AU (1) AU760960B2 (fr)
BR (1) BR9914904A (fr)
CA (1) CA2348495C (fr)
WO (1) WO2000026698A1 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6416550B2 (en) 1998-04-15 2002-07-09 Alcon Manufacturing, Ltd. Method of selecting an intraocular lens material
US6491721B2 (en) 1998-04-15 2002-12-10 Alcon Manufacturing, Ltd. Toric intraocular lens material
US6271281B1 (en) 1999-08-26 2001-08-07 Medennium, Inc. Homopolymers containing stable elasticity inducing crosslinkers and ocular implants made therefrom
ES2235935T3 (es) 1999-09-07 2005-07-16 Alcon Inc. Materiales para dispositivos otorrinolaringologicos y oftalmicos plegables.
US6679605B2 (en) * 2000-05-22 2004-01-20 Medennium, Inc. Crystalline polymeric compositions for ophthalmic devices
US7173073B2 (en) 2002-01-14 2007-02-06 Johnson & Johnson Vision Care, Inc. Ophthalmic devices containing heterocyclic compounds and methods for their production
US20040150788A1 (en) 2002-11-22 2004-08-05 Ann-Margret Andersson Antimicrobial lenses, processes to prepare them and methods of their use
US7416737B2 (en) 2003-11-18 2008-08-26 Johnson & Johnson Vision Care, Inc. Antimicrobial lenses, processes to prepare them and methods of their use
US8158037B2 (en) 2005-04-08 2012-04-17 Johnson & Johnson Vision Care, Inc. Photochromic materials having extended pi-conjugated systems and compositions and articles including the same
US9052438B2 (en) 2005-04-08 2015-06-09 Johnson & Johnson Vision Care, Inc. Ophthalmic devices comprising photochromic materials with reactive substituents
US20080102095A1 (en) 2006-10-31 2008-05-01 Kent Young Acidic processes to prepare antimicrobial contact lenses
US7968650B2 (en) 2006-10-31 2011-06-28 Johnson & Johnson Vision Care, Inc. Polymeric compositions comprising at least one volume excluding polymer
KR100885819B1 (ko) * 2007-12-18 2009-02-26 제일모직주식회사 굴절률이 우수한 분지형 아크릴계 공중합체 및 그 제조방법
US8877103B2 (en) 2010-04-13 2014-11-04 Johnson & Johnson Vision Care, Inc. Process for manufacture of a thermochromic contact lens material
US9690115B2 (en) 2010-04-13 2017-06-27 Johnson & Johnson Vision Care, Inc. Contact lenses displaying reduced indoor glare
US8697770B2 (en) 2010-04-13 2014-04-15 Johnson & Johnson Vision Care, Inc. Pupil-only photochromic contact lenses displaying desirable optics and comfort
JP5794503B2 (ja) * 2010-08-16 2015-10-14 学校法人愛知学院 形状記憶樹脂及びそれを用いた歯列矯正器具、並びに形状記憶樹脂の粘弾特性の制御方法
WO2012122320A2 (fr) * 2011-03-07 2012-09-13 The Regents Of The University Of Colorado, A Body Corporate Lentilles intraoculaires en polymère à mémoire de forme
CN103534284A (zh) * 2011-05-23 2014-01-22 松下电器产业株式会社 甲基丙烯酸系树脂组合物及其成型体
US8865685B2 (en) 2011-06-30 2014-10-21 Johnson & Johnson Vision Care, Inc. Esters for treatment of ocular inflammatory conditions
US20130083287A1 (en) 2011-09-30 2013-04-04 Johnson & Johnson Vision Care, Inc. Method of creating a visible mark on lens using a leuco dye
US20130083286A1 (en) 2011-09-30 2013-04-04 Johnson & Johnson Vision Care, Inc. Method of creating a visible mark on lens using a leuco dye
US11724471B2 (en) 2019-03-28 2023-08-15 Johnson & Johnson Vision Care, Inc. Methods for the manufacture of photoabsorbing contact lenses and photoabsorbing contact lenses produced thereby

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2517281B2 (ja) * 1987-05-28 1996-07-24 富士写真フイルム株式会社 光重合性組成物
US4834750A (en) * 1987-09-17 1989-05-30 Ioptex Research, Inc. Deformable-elastic intraocular lens
EP0514096A3 (en) * 1991-05-13 1993-03-31 Ioptex Research Inc. Deformable-elastic intraocular lens
JP3191011B2 (ja) * 1992-06-02 2001-07-23 日立金属株式会社 ２成分現像剤
US5331073A (en) * 1992-11-09 1994-07-19 Allergan, Inc. Polymeric compositions and intraocular lenses made from same
CA2138299C (fr) * 1993-04-30 1998-07-14 Albert R. Leboeuf Methode pour la reduction du caractere poisseux de polymeres acryliques mous
JP2967093B2 (ja) * 1995-02-23 1999-10-25 ホーヤ株式会社 軟性眼内レンズ
JPH08299373A (ja) * 1995-05-12 1996-11-19 Hoya Corp 軟性眼内レンズ及びその製造方法
JP3429392B2 (ja) * 1995-05-24 2003-07-22 Ｈｏｙａ株式会社 軟性眼内レンズ

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO0026698A1 *

Also Published As

Publication number Publication date
AU760960B2 (en) 2003-05-22
WO2000026698B1 (fr) 2000-07-13
JP2007262414A (ja) 2007-10-11
WO2000026698A8 (fr) 2001-09-13
CA2348495C (fr) 2008-07-15
AU4608701A (en) 2002-02-05
BR9914904A (pt) 2001-08-07
WO2000026698A1 (fr) 2000-05-11
JP5096793B2 (ja) 2012-12-12
JP2002529759A (ja) 2002-09-10
CA2348495A1 (fr) 2000-05-11

Similar Documents

Publication Publication Date Title
US6241766B1 (en) Intraocular lenses made from polymeric compositions
EP0667966B1 (fr) Compositions polymeres et lentilles intraoculaires constituees desdites compositions
CA2348495C (fr) Lentilles intraoculaires de compositions polymeriques
US6245106B1 (en) Intraocular lenses made from polymeric compositions and monomers useful in said compositions
US6635731B2 (en) Water plasticized high refractive index polymer for ophthalmic applications
EP1289740B1 (fr) Compositions polymeriques cristallines destinees a produire des materiels ophtalmologiques
USRE36150E (en) Deformable-elastic intraocular lens
AU2003249203B2 (en) Ophthalmic and otorhinolaryngological device materials
CA2382458A1 (fr) Homopolymeres contenant des agents de reticulation et implants oculaires produits a partir de ceux-ci
EP1080382B1 (fr) Materiaux pour dispositifs ophtalmiques a indice de refraction eleve
AU661306B2 (en) Deformable-elastic intraocular lens
US8753389B1 (en) Sterilization of intraocular lenses
USRE38935E1 (en) Intraocular lenses made from polymeric compositions and monomers useful in said compositions
MXPA00006399A (en) High refractive index ophthalmic device materials

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010417

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: ADVANCED MEDICAL OPTICS, INC.

17Q First examination report despatched

Effective date: 20040421

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20051213